National Bank of Canada’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,147,145
Closed -$8.24M 2866
2023
Q1
$8.24M Buy
1,147,145
+79,965
+7% +$620K 0.02% 467
2022
Q4
$8.73M Buy
1,067,180
+1,045,639
+4,854% +$9.75M 0.02% 461
2022
Q3
$226K Sell
21,541
-6,330
-23% -$67.3K ﹤0.01% 1335
2022
Q2
$268K Sell
27,871
-2,021
-7% -$16.5K ﹤0.01% 1341
2022
Q1
$203K Buy
29,892
+2,800
+10% +$18K ﹤0.01% 1502
2021
Q4
$214K Buy
+27,092
New +$180K ﹤0.01% 1444

Other funds holding BLU

National Bank of Canada's BLU Position: Q2 2023 in Review

National Bank of Canada sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 1,147,145 shares — an estimated $8.24M sold.

National Bank of Canada first reported a position in BLU in Q4 2021 and held it in 6 quarters. The position peaked at $8.73M in Q4 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • National Bank of Canada reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • National Bank of Canada sold 1,147,145 BELLUS Health Inc. shares in Q2 2023, an estimated $8.24M.
  • National Bank of Canada first reported a position in BELLUS Health Inc. in Q4 2021 and held it in 6 quarters.
  • National Bank of Canada's BELLUS Health Inc. position peaked at $8.73M in Q4 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on National Bank of Canada's 13F filing for Q2 2023, filed 26 Jul 2023.